Literature DB >> 31962301

A prognostic analysis method for non-small cell lung cancer based on the computed tomography radiomics.

Xu Wang1, Huihong Duan, Xiaobing Li, Xiaodan Ye, Gang Huang, Shengdong Nie.   

Abstract

In order to assist doctors in arranging the postoperative treatments and re-examinations for non-small cell lung cancer (NSCLC) patients, this study was initiated to explore a prognostic analysis method for NSCLC based on computed tomography (CT) radiomics. The data of 173 NSCLC patients were collected retrospectively and the clinically meaningful 3-year survival was used as the predictive limit to predict the patient's prognosis survival time range. Firstly, lung tumors were segmented and the radiomics features were extracted. Secondly, the feature weighting algorithm was used to screen and optimize the extracted original feature data. Then, the selected feature data combining with the prognosis survival of patients were used to train machine learning classification models. Finally, a prognostic survival prediction model and radiomics prognostic factors were obtained to predict the prognosis survival time range of NSCLC patients. The classification accuracy rate under cross-validation was up to 88.7% in the prognosis survival analysis model. When verifying on an independent data set, the model also yielded a high prediction accuracy which is up to 79.6%. Inverse different moment, lobulation sign and angular second moment were NSCLC prognostic factors based on radiomics. This study proved that CT radiomics features could effectively assist doctors to make more accurate prognosis survival prediction for NSCLC patients, so as to help doctors to optimize treatment and re-examination for NSCLC patients to extend their survival time.

Entities:  

Year:  2020        PMID: 31962301     DOI: 10.1088/1361-6560/ab6e51

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  7 in total

1.  A Prognostic Model of Non-Small Cell Lung Cancer With a Radiomics Nomogram in an Eastern Chinese Population.

Authors:  Lijie Wang; Ailing Liu; Zhiheng Wang; Ning Xu; Dandan Zhou; Tao Qu; Guiyuan Liu; Jingtao Wang; Fujun Yang; Xiaolei Guo; Weiwei Chi; Fuzhong Xue
Journal:  Front Oncol       Date:  2022-06-14       Impact factor: 5.738

2.  Impact of feature selection methods and subgroup factors on prognostic analysis with CT-based radiomics in non-small cell lung cancer patients.

Authors:  Yuto Sugai; Noriyuki Kadoya; Shohei Tanaka; Shunpei Tanabe; Mariko Umeda; Takaya Yamamoto; Kazuya Takeda; Suguru Dobashi; Haruna Ohashi; Ken Takeda; Keiichi Jingu
Journal:  Radiat Oncol       Date:  2021-04-30       Impact factor: 3.481

Review 3.  Artificial intelligence-assisted decision making for prognosis and drug efficacy prediction in lung cancer patients: a narrative review.

Authors:  Jingwei Li; Jiayang Wu; Zhehao Zhao; Qiran Zhang; Jun Shao; Chengdi Wang; Zhixin Qiu; Weimin Li
Journal:  J Thorac Dis       Date:  2021-12       Impact factor: 2.895

4.  MS-ResNet: disease-specific survival prediction using longitudinal CT images and clinical data.

Authors:  Jiahao Han; Ning Xiao; Wanting Yang; Shichao Luo; Jun Zhao; Yan Qiang; Suman Chaudhary; Juanjuan Zhao
Journal:  Int J Comput Assist Radiol Surg       Date:  2022-04-20       Impact factor: 3.421

5.  Machine-Learning-Derived Nomogram Based on 3D Radiomic Features and Clinical Factors Predicts Progression-Free Survival in Lung Adenocarcinoma.

Authors:  Guixue Liu; Zhihan Xu; Yaping Zhang; Beibei Jiang; Lu Zhang; Lingyun Wang; Geertruida H de Bock; Rozemarijn Vliegenthart; Xueqian Xie
Journal:  Front Oncol       Date:  2021-06-23       Impact factor: 6.244

6.  Predictive Radiomic Models for the Chemotherapy Response in Non-Small-Cell Lung Cancer based on Computerized-Tomography Images.

Authors:  Runsheng Chang; Shouliang Qi; Yong Yue; Xiaoye Zhang; Jiangdian Song; Wei Qian
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

Review 7.  [Research Advances and Obstacles of CT-based Radiomics in Diagnosis and Treatment of Lung Cancer].

Authors:  Jiawei Li; Xiadong Li; Xueqin Chen; Shenglin Ma
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-08-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.